|[August 27, 2014]
Making Science Fiction a Science Reality: Finalist Teams Selected for $10 Million Qualcomm Tricorder XPRIZE
CHICAGO --(Business Wire)--
the global leader in incentivized prize competitions, today announced
the 10 finalist teams competing for the $10M
Qualcomm Tricorder XPRIZE, a 3.5-year global competition sponsored
by the Qualcomm (News - Alert) Foundation for teams to develop a consumer-focused
mobile device capable of diagnosing and interpreting a set of 15 medical
conditions and capturing five vital health metrics. Launched in January
2012, the competition encourages the development of a device much like
the medical Tricorder of Star Trek® fame,
moving it from science fiction to science reality.
Announced during the opening ceremony of the IEEE
Engineering in Medicine and Biology Society International Conference,
the group of finalists competing for the Qualcomm Tricorder XPRIZE
includes a wide range of expertise and backgrounds, representing
non-profits and academia to start-ups and established device
manufacturers from six countries. The 10 teams advancing to the Final
Aezon (Rockville, Md.), led by Tatiana Rypinski, a team of
student engineers from Johns Hopkins University partnering with the
Center for Bioengineering Innovation & Design.
CloudDX (Mississauga, Canada), a team from medical devices
manufacturer Biosign and led by company chief medical officer, Dr.
Danvantri (Chennai, India), a team from technology manufacturer
American Megatrends India and led by company Director and CEO,
DMI (Cambridge, Mass.), a team led by Dr. Eugene Y. Chan of the
DNA Medicine Institute partnering with NASA, the National Institutes
of Health and the Bill and Melinda Gates Foundation.
Dynamical Biomarkers Group (Zhongli City, Taiwan), a team of
physicians, scientists and engineers led by Harvard Medical School
proessor Chung-Kang Peng.
Final Frontier Medical Devices (Paoli, Pa.), a team led by the
founders of Basil Leaf Technologies-brothers Dr. Basil Harris, an
emergency room physician, and George Harris, a network engineer.
MESI Simplifying diagnostics (Ljubljana, Slovenia), a team from
diagnostic medical device manufacturer MESI and led by company CEO,
SCANADU (Moffett Field, Calif.), a team from Silicon
Valley-based start-up SCANADU, led by technology entrepreneur and
company co-founder and CEO, Walter De Brouwer.
SCANurse (London, England), a team from diagnostic medical
manufacturer SCANurse and led by biomedical engineer and company
founder, Anil Vaidya.
zensor (Belfast, Ireland), a team from clinical sensor and
electrode company Intelesens and led by chief technology officer,
Prof. Jim McLaughlin.
For more information about each team, visit http://www.qualcommtricorderxprize.org/teams.
"Our selected finalists represent the most promising and innovative
submissions as determined by our expert judging panel," said Grant
Campany, senior director, Qualcomm Tricorder XPRIZE. "We want consumers
to take a more proactive approach to managing their health and having
convenient access to real-time medical data will do just that. As we
move to the final stage of this process, we are one step closer to
putting healthcare in the palm of your hand."
During the Qualifying Round, each team was required to submit an entry
that addressed safety, user experience and a health assessment
evaluation. The judging panel, comprised of various digital health and
medical industry experts, reviewed 21 team submissions from nine
countries and selected the 10 most credible entries.
"The technologies being created for the Qualcomm Tricorder XPRIZE can
have an exponential, global impact, not only on remotely diagnosing
diseases, but on a myriad of other medical areas, including continuous
health monitoring, disease prevention and chronic disease management,"
said Rick Valencia, Sr. Vice President & General Manager, Qualcomm Life.
"It will certainly be exciting to see these devices materialize as we
move closer to the competition's end."
As part of the Final Round, teams will compete in both diagnostic
experience evaluations and consumer testing, slated for mid-to-late
2015. The final judging and awards ceremony will take place in early
Throughout the competition, the U.S. Food and Drug Administration (FDA)
is offering regulatory input to the competing teams to help them prepare
for potential FDA review post-competition.
For more information about the Qualcomm Tricorder XPRIZE, visit http://www.qualcommtricorderxprize.org.
Founded in 1995, XPRIZE is the leading organization solving the world's
Grand Challenges by creating and managing large-scale, high-profile,
incentivized prizes in five areas: Learning; Exploration; Energy &
Environment; Global Development; and Life Sciences. Active prizes
include the $30M Google Lunar XPRIZE, the $10M Qualcomm Tricorder
XPRIZE, the $2.25M Nokia (News - Alert) Sensing XCHALLENGE and the $2M Wendy Schmidt
Ocean Health XPRIZE. For more information, visit www.xprize.org.
About the Qualcomm Foundation
Established in 2010 by Qualcomm Incorporated, the Qualcomm Foundation is
dedicated to developing and strengthening communities worldwide.
Specifically, the Qualcomm Foundation focuses its philanthropic efforts
on helping create and sustain educated, healthy, culturally vibrant
communities in regions around the globe. For more information about the
Qualcomm Foundation and Qualcomm Incorporated's global social
responsibility programs, visit www.qualcomm.com/community.
Qualcomm is a trademark of Qualcomm Incorporated, registered in the
United States and other countries.
STAR (News - Alert) TREK, TRICORDER and
related marks and logos are trademarks of CBS Studios Inc. Used under
[ InfoTech Spotlight's Homepage ]